Compare Wegovy vs Mounjaro Mechanisms And Dosing
What's The Difference Between Wegovy And Mounjaro Active Ingredients?
The fundamental difference between Wegovy and Mounjaro lies in their active pharmaceutical ingredients and mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone GLP-1 to promote feelings of fullness and reduce appetite. Mounjaro contains tirzepatide, which targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, creating a dual hormone approach to weight management. Both prescription-only medicines work by affecting brain appetite centres, but their different receptor targets may influence individual response patterns. Your prescriber can help determine which mechanism may be more appropriate for your specific health profile and weight management goals.
The dosing schedules also differ significantly between these two treatments. Wegovy follows a 5-dose escalation protocol: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance dose from week 17 onwards. Mounjaro uses a 6-dose escalation spanning 2.5mg to 15mg maximum dose, with different timing intervals. Both medicines require gradual dose increases to minimise side effects, but the specific escalation patterns and final maintenance doses vary considerably. This difference in dosing complexity can influence treatment planning and long-term adherence strategies.
Wegovy vs Mounjaro Pricing Comparison At EverydayMeds
EverydayMeds offers competitive pricing for both Wegovy and Mounjaro, allowing patients to compare costs transparently. Wegovy single pens start at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Our 2-pen Getting Started bundles provide convenient dose progression: Intro Duo (0.25mg & 0.5mg) for £169.99, Progress Duo (0.5mg & 1mg) for £189.99, and Advance Duo (1mg & 1.7mg) for £269.99. New customers can apply discount code FIRST40 at checkout, while returning customers use DOSE25 to access these competitive prices.
For patients requiring longer-term supply planning, our 3-pen bundles offer extended coverage without multiple orders. The Intro Trio (0.25mg, 0.5mg & 1mg) costs £299.99, covering the first three escalation phases completely. The Ultimate Stability Trio provides three months of maintenance 2.4mg doses for £649.99, ensuring consistent supply for established patients. Take-It-Slow bundles like our Gentle Start Trio (0.25mg, 0.25mg, 0.5mg) for £269.99 accommodate patients who prefer extended starter phases. All pricing includes our clinical assessment, prescriber review, and next-day cold-chain delivery service.
Clinical Evidence: What's The Difference Between Wegovy And Mounjaro Trials?
Wegovy's clinical evidence comes primarily from the STEP trial programme, with STEP 1 demonstrating average weight loss of approximately 15% at 68 weeks when used alongside diet and exercise interventions. The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, highlighting potential benefits beyond weight management. However, direct head-to-head comparisons between Wegovy and Mounjaro are limited due to different trial designs, patient populations, and study endpoints.
Both medicines have undergone rigorous clinical testing, but comparing their efficacy percentages directly would be misleading given the different trial methodologies employed. Wegovy trials focused on specific BMI thresholds and weight-related comorbidities, while Mounjaro studies examined different patient populations and outcome measures. Individual response to either treatment can vary significantly based on genetic factors, lifestyle adherence, and underlying health conditions that influence hormone receptor sensitivity.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of naturally occurring incretin hormones that regulate appetite and glucose metabolism. When administered as a once-weekly injection, semaglutide binds to GLP-1 receptors in the brain's hypothalamus, the region responsible for appetite control and satiety signalling. This binding action triggers a cascade of neurochemical responses that reduce hunger sensations and promote earlier feelings of fullness during meals. The medicine also slows gastric emptying, meaning food remains in the stomach longer, contributing to sustained satiety between meals. Additionally, GLP-1 receptor activation can reduce food cravings and the reward response associated with high-calorie foods, potentially supporting better dietary choices throughout treatment.
Ordering Process: What's The Difference Between Wegovy And Mounjaro Access?
Both Wegovy and Mounjaro are available through EverydayMeds' streamlined online service, though the assessment process considers the different mechanisms and dosing requirements for each treatment. Patients complete our 3-minute clinical questionnaire covering medical history, current medications, weight management goals, and lifestyle factors. Our qualified prescribers review each application within 3 working days (or 24 hours with express service), considering which treatment option aligns best with individual patient profiles. Once approved, both medicines are dispatched via next-day delivery using temperature-controlled packaging to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all prescribing and dispensing meets UK regulatory standards for prescription-only medicines.
Storage Differences: Wegovy vs Mounjaro Practical Advantages
A significant practical difference between Wegovy and Mounjaro lies in their storage requirements and temperature tolerance. Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, providing substantial flexibility for travel, work schedules, and daily life management. Mounjaro pens tolerate only 21 days at room temperature, requiring more careful planning for extended trips or situations where refrigeration isn't readily available. Both medicines should ideally be stored in the refrigerator between 2-8°C before first use, but Wegovy's extended room temperature stability offers practical advantages for many patients. The FlexTouch pen system used for Wegovy delivery is pre-filled and disposable, eliminating the need for separate needles or complex preparation procedures.
What's The Difference Between Wegovy And Mounjaro Patient Suitability?
Patient suitability for Wegovy versus Mounjaro often depends on individual response to different hormone pathways and tolerance profiles. Wegovy's single GLP-1 mechanism may be preferred for patients who have previously responded well to incretin-based therapies or those seeking a well-established treatment with extensive cardiovascular outcome data. The medicine is licensed for adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities, alongside adolescents ≥12 years meeting specific criteria. NICE guidance (TA875) recommends Wegovy with specialist weight management support, emphasising the importance of comprehensive lifestyle interventions.
Mounjaro's dual receptor approach may appeal to patients seeking novel mechanisms or those who haven't achieved desired outcomes with single-target therapies. However, both treatments require commitment to long-term lifestyle modifications, as the STEP 1 extension study demonstrated that patients regained approximately two-thirds of lost weight within one year of stopping treatment. The choice between these medicines should involve detailed discussion with healthcare providers about medical history, treatment goals, lifestyle factors, and long-term sustainability planning.
Compare Both Treatments With Expert EverydayMeds Support
EverydayMeds uniquely positions patients to access both Wegovy and Mounjaro through a single platform, enabling informed treatment decisions without switching providers. Our clinical team understands the nuanced differences between semaglutide and tirzepatide mechanisms, helping patients navigate the choice based on individual circumstances rather than limited formulary options. Whether you're starting your first weight management medication or considering switching treatments, our prescribers can evaluate both options objectively. Using discount codes FIRST40 (new customers) or DOSE25 (returning customers), patients can access competitive pricing for either treatment with the same high-quality service standards. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which is right for you based on comprehensive clinical assessment and ongoing monitoring requirements.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
